A citation-based method for searching scientific literature

Benjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, C Michael Gibson, Duane Pinto, Robert P Giugliano, Matthew J Budoff, Jean-Claude Tardif, Subodh Verma, Christie M Ballantyne. Circulation 2021
Times Cited: 28



Prakriti Gaba, Deepak L Bhatt, Robert P Giugliano, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle, Craig Granowitz, Jean-Claude Tardif, Christie M Ballantyne, Duane S Pinto, Matthew J Budoff, C Michael Gibson. J Am Coll Cardiol 2021
Times Cited: 11




List of shared articles



Times cited

Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT.
Prakriti Gaba, Deepak L Bhatt, R Preston Mason, Michael Miller, Subodh Verma, Ph Gabriel Steg, William E Boden. J Clin Lipidol 2022
0

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment.
William S Weintraub, Deepak L Bhatt, Zugui Zhang, Sarahfaye Dolman, William E Boden, Adam P Bress, Jordan B King, Brandon K Bellows, Gabriel S Tajeu, Catherine G Derington,[...]. JAMA Netw Open 2022
3

Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction.
Prakriti Gaba, Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Rebecca A Juliano, Lixia Jiao, Ralph T Doyle,[...]. J Am Coll Cardiol 2022
6

The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl.
Catherine G Derington, Adam P Bress, Jennifer S Herrick, Wenjun Fan, Nathan D Wong, Katherine E Andrade, Jonathan Johnson, Sephy Philip, David Abrahamson, Lixia Jiao,[...]. Am J Prev Cardiol 2022
0